Stocks gapping ≥20% at open — earnings flagged, AI catalyst research included
| Date | Ticker | Company | Sector | MCap | Prev Close | Open | Gap% | Earnings | Type | Conf |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11 Mon | POM | POMDOCTOR Ltd | Healthcare | 56M | — | $0.09 | +20.0% | — | — | 0 |
| Source documents provided contain only securities class action lawsuit reminders for PomDoctor Ltd. (NASDAQ: POM) with a lead plaintiff deadline of April 13, 2026, covering purchases between October 9, 2025 and December 11, 2025. No information about positive catalysts, contracts, approvals, guidance raises, earnings beats, partnerships, buybacks, or other events that would cause a 20% gap up is present in the available sources dated on or before May 11, 2026. | ||||||||||
| CEVA | CEVA, Inc. | Technology | 939M | $36.97 | $42.35 | +14.6% | BMO | beat | 9 | |
| CEVA reported Q1 2026 non-GAAP diluted EPS of $0.04, beating Zacks Consensus Estimate of $0.02 per share. Total revenues were $27.0 million, up 11% YoY. Licensing and related revenues reached $17.8 million, up 18% YoY and the highest in three years. AI represented over 20% of licensing revenues with major production milestone: Ceva's AI DSP deployed in Renesas R-Car V4H platform entering 2026 Toyota RAV4. Signed 14 IP licensing agreements including major Bluetooth HDT full-stack solution with RF | ||||||||||
| May 7 Thu | RXT | Rackspace Technology, Inc. | Technology | 869M | $2.27 | — | +75.3% | BMO | partner | 7 |
| Rackspace Technology and AMD signed a Memorandum of Understanding to establish a new category of governed Enterprise AI Infrastructure, with CEO Gajen Kandiah stating 'It is a category Rackspace is built to lead.' | ||||||||||
| INOD | Innodata Inc. | Technology | 1.5B | $45.64 | $72.92 | +59.8% | AMC | contract | 8 | |
| New engagement with unnamed 'Big Tech Company' expected to generate approximately $51 million of revenue in 2026; customer was zero revenue 12 months ago and expected to become second-largest customer; combined 'other Big Tech customers' revenue grew 453% year-over-year in Q1 2026 | ||||||||||
| AAON | AAON, Inc. | Industrials | 10.6B | $98.30 | — | +45.5% | BMO | — | 9 | |
| Q1 2026 revenue beat: $496.9M (54.3% YoY growth) vs implied consensus; GAAP diluted EPS $0.48 (37.1% YoY growth) vs $0.35 prior year. FY2026 guidance raised to 40%-45% revenue growth (from prior 18%-20%) and gross margin 27%-28% (from prior 29%-31%). Record backlog of $2.129B (107.4% YoY increase), with BASX backlog up 160.0% driven by data center cooling demand. | ||||||||||
| XMTR | Xometry, Inc. | Industrials | 3.9B | $56.40 | — | +34.8% | BMO | partner | 9 | |
| Siemens strategic partnership with $50 million equity investment in Xometry (XMTR). Siemens embedding Xometry's AI-native manufacturability, pricing, sourcing and execution intelligence into Siemens Xcelerator platform, plus integration of Thomas-Xometry North American industrial sourcing network with Siemens Supplyframe. | ||||||||||
| DDOG | Datadog, Inc. | Technology | 67.0B | $143.71 | — | +30.8% | BMO | beat | 9 | |
| Q1 2026 revenue of $1,006 million beat expectations with 32% YoY growth; non-GAAP EPS of $0.60 vs GAAP EPS of $0.15; $100k+ ARR customers increased 21% to 4,550 from 3,770 YoY; FY2026 guidance raised to $4.30-4.34 billion revenue (midpoint $4.32B) and non-GAAP EPS of $2.36-2.44 (midpoint $2.40) | ||||||||||
| HIMX | Himax Technologies, Inc. | Technology | 2.8B | $12.33 | — | +25.1% | BMO | other | 1 | |
| No specific catalyst for HIMX identified in provided sources. Sources discuss Apple-Intel chip deal, Apple AI initiatives, and Apple price target raises by Wedbush, but contain no mention of Himax Technologies (HIMX), its products, contracts, earnings, or guidance. | ||||||||||
| AKAM | Akamai Technologies, Inc. | Technology | 17.2B | $116.69 | $145.45 | +24.6% | AMC | contract | 8 | |
| A leading frontier model provider (AI company) committed $1.8 billion over seven years for Cloud Infrastructure Services, announced on 2026-05-07 | ||||||||||
| JMIA | Jumia Technologies AG | Consumer Cyclical | 539M | $7.46 | — | +22.4% | BMO | other | 0 | |
| No specific catalyst identified for JMIA gap-up in provided sources. All documents discuss Apple, Intel, and other unrelated companies with no mention of Jumia Technologies (JMIA). | ||||||||||
| PGNY | Progyny, Inc. | Healthcare | 1.6B | $19.16 | $23.39 | +22.1% | AMC | beat | 9 | |
| Q1 2026 Revenue of $328.5M vs Q1 2025 $324.0M (+1.4% YoY); Net Income $0.29 per diluted share vs $0.17 prior year (+70.6%); Adjusted EPS $0.50 vs $0.48 consensus; Gross Margin expanded to 25.3% from 23.4%; FY2026 guidance raised to $1.365B-$1.405B revenue (5.9%-9.0% growth) and Adjusted EPS $1.98-$2.09; 595 fertility clients vs 532 prior year; 7.185M average members vs 6.695M prior year | ||||||||||
| May 6 Wed | AGL | Agilon Health, Inc. | Healthcare | 1.0B | $27.85 | $43.59 | +56.5% | AMC | guidance | 8 |
| Full-year 2026 Total Revenues guidance raised from $5,410-$5,580M to $5,680-$5,805M; Medical Margin raised from $300-$350M to $350-$400M; Adjusted EBITDA raised from ($15)-$15M to $10-$40M. Q1 2026 Adjusted EBITDA beat at $54M vs $21M prior year (+162%). | ||||||||||
| FLNC | Fluence Energy, Inc. | Utilities | 3.5B | $13.56 | $19.20 | +41.6% | AMC | contract | 8 | |
| Order intake doubled year-to-date to $2.0 billion (vs $1.0 billion prior year); signed master supply agreements with two major hyperscalers with first order expected Q3 FY2026; backlog reached record $5.6 billion as of March 31, 2026 | ||||||||||
| SITM | SiTime Corporation | Technology | 21.0B | $623.33 | $835.05 | +34.0% | AMC | beat | 8 | |
| Q1 2026 revenue of $113.6M (88.3% YoY growth vs $60.3M in Q1 2025); non-GAAP EPS of $1.44 per diluted share; non-GAAP gross margin expanded to 64.5% from 57.4% YoY; non-GAAP operating income of $31.8M vs $2.1M in Q1 2025 | ||||||||||
| OSG | Octave Specialty Group, Inc. | Financial Services | 273M | $4.22 | $5.35 | +26.8% | AMC | beat | 8 | |
| Insurance Distribution segment delivered 92% revenue growth to $78.5 million (vs. $41.0 million in 1Q25), with Adjusted EBITDA surging 256% to $25.3 million to shareholders; company reported Adjusted net income of $0.37 per diluted share vs. loss of $(0.13) per share in 1Q25, driven by ArmadaCare acquisition (October 2025) and 42% organic revenue growth. | ||||||||||
| FLEX | Flex Ltd. | Technology | 48.9B | $96.45 | — | +24.3% | BMO | guidance | 9 | |
| FY2027 adjusted EPS guidance raised to $4.21-$4.51 (32% growth at midpoint) vs FY2026 adjusted EPS of $3.30; FY2027 revenue guidance $32.3-$33.8 billion (18% growth at midpoint) vs FY2026 revenue of $27.9 billion; announced planned spin-off of Cloud and Power Infrastructure segment | ||||||||||
| PCT | PureCycle Technologies, Inc. | Industrials | 1.6B | $7.62 | $9.32 | +22.3% | AMC | partner | 8 | |
| Procter & Gamble (P&G) final approval for commercialization of two applications with PureFive resin; first P&G application qualified and slated for first pellet delivery in Q2 2026; second application expected to ship in 2H 2026. Joint product quality study showed PureCycle process achieves highest CosPaTox purity rating. | ||||||||||
| May 5 Tue | EVC | Entravision Communications Corporation | Communication Services | 639M | $3.98 | $6.49 | +63.1% | AMC | beat | 9 |
| Q1 2026 consolidated net revenue $196.971 million (+114% YoY) vs Q1 2025 $91.851 million; ATS segment revenue $154.550 million (+204% YoY) driven by AI platform investments and expanded sales capacity; EPS $0.13 vs prior year loss of ($0.53); segment operating profit $29.1 million vs $3.9 million | ||||||||||
| COMP | Compass, Inc. | Technology | 5.3B | $7.26 | $9.28 | +27.8% | AMC | guidance | 8 | |
| Compass raised 2026 realized cost synergy target from $100 million to $200 million and increased actioned cost synergy target from $250 million to $300 million, while delivering Q1 2026 revenue of $2.70 billion (99% YoY increase) with Adjusted EBITDA of $61 million above high-end guidance range and pro forma Brokerage GTV +7.3% YoY outperforming market at +1.5%. | ||||||||||
| VECO | Veeco Instruments Inc. | Technology | 3.5B | $49.54 | $62.25 | +25.7% | AMC | other | 1 | |
| No earnings, revenue, contract, partnership, guidance, or financial catalyst found in the 8-K filed on 2026-05-07. The document reports only routine annual meeting voting results held on May 7, 2026, with director elections and shareholder approvals (Stock Incentive Plan amendment, executive compensation advisory vote, auditor ratification by KPMG LLP). | ||||||||||
8–10 = trade signal
5–7 = research more
0–4 = stay out / no clear catalyst
Orange sector = Healthcare (binary event risk)
· Hover sector for industry · Hover ticker for price chart